Workflow
华峰化学(002064):业绩短期承压,推进一体化布局

Investment Rating - The report maintains a "Strong Buy" rating for Huafeng Chemical [2][4]. Core Views - Huafeng Chemical's performance is under short-term pressure due to declining product prices, with a year-on-year revenue decrease of 11.70% to 12.137 billion yuan and a net profit drop of 35.23% to 983 million yuan in the first half of 2025 [3]. - The company is focusing on expanding its production capacity and enhancing its integrated supply chain to strengthen its cost advantages and scale [4]. - The company is a leader in the production of spandex, adipic acid, and polyurethane raw materials, with significant scale, technology, and cost advantages [4]. Financial Performance Summary - In the first half of 2025, Huafeng Chemical's revenue from its three main business segments—chemical fibers, new chemical materials, and basic chemical products—declined by 9.43%, 8.82%, and 15.04% respectively [3]. - The company's gross profit margin decreased by 2.75 percentage points to 13.77% due to the impact of falling product prices [3]. - The company has a production capacity of 325,000 tons for spandex, with an additional 150,000 tons under construction, and is the largest producer of adipic acid and polyurethane raw materials in China [3]. Capacity Expansion and Integration - Huafeng Chemical is investing in upstream raw material projects, including a 1.1 million ton natural gas integration project and a 240,000 ton PTMEG spandex project, which are expected to enhance its cost advantages in spandex production [4]. - The company aims to further strengthen its scale advantages as it continues to develop its production capacity in the polyurethane industry [4]. Profit Forecast - The report forecasts net profits for Huafeng Chemical to be 2.133 billion yuan, 2.403 billion yuan, and 2.664 billion yuan for 2025, 2026, and 2027 respectively, with corresponding EPS of 0.43 yuan, 0.48 yuan, and 0.54 yuan [4][5].